Targeting the CLK2/SRSF9 splicing axis in prostate cancer leads to decreased ARV7 expression

In advanced prostate cancer (PC), in particular after acquisition of resistance to androgen receptor (AR) signaling inhibitors (ARSI), upregulation of AR splice variants compromises endocrine therapy efficiency. Androgen receptor splice variant‐7 (ARV7) is clinically the most relevant and has a dist...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Jasper Van Goubergen, Miroslav Peřina, Florian Handle, Elisa Morales, Anika Kremer, Oliver Schmidt, Glen Kristiansen, Marcus V. Cronauer, Frédéric R. Santer
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2025-02-01
Edice:	Molecular Oncology
Témata:	3′ untranslated region allele‐specific regulation androgen receptor splice variant 7 dual specificity protein kinase CLK2 serine/arginine‐family of splicing factors splicing inhibitors
On-line přístup:	https://doi.org/10.1002/1878-0261.13728
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!